Heart Valve Devices – Market Insights – Asia Pacific

The Asia Pacific heart valve device market will continue to experience robust growth after recovering from the impact of COVID-19. The market will be primarily driven by rapid adoption of THV devices, positive results from THV device clinical trials and emergence of novel devices and device types generating continued growth in this market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in the Asia Pacific region from 2019 through 2032.

The Asia Pacific heart valve replacement device market will be driven by rapid adoption of TAVR.

How will the market react to the approval of new TAVR devices?

Which new TAVR devices are poised to enter the market? What impact will these newer devices have on market dynamics and market growth?

How does different factors influence the adoption of TAVR devices across the geography?

How does the presence of domestic players impact the TAVR market?

How are companies leveraging the first mover advantage in the Asia Pacific heart valve replacement device market?

The market landscape evolving for surgical heart valve replacement and surgical annuloplasty repair devices.

How will new THV device technologies affect the surgical repair and replacement device markets?

How is the adoption of TMVR device in Latin America impacting the heart valve device market?

How significantly does the high cost of TMVR impact adoption in the Asia Pacific region?

When is TMVI therapy expected to enter the Asia Pacific market? What TMVI devices are in development?

Companies are following different strategies to succeed in the heart valve device market.

What different strategies are companies following?

Which companies are the major players in this space?

How does the presence of local competitors differ by country?

How will physician perception impact the brand preference in the Asia Pacific heart valve device market?

How does the cost-sensitive nature of Asia Pacific countries affect the Asia Pacific heart valve device market?

Clinical trial results play an important factor in the heart valve device market.

How are clinical studies and guidelines impacting the uptake of THV replacement devices?

What will be the market impact of the approval of expanded indications for TAVR?

What technologies are larger players focusing on and how will the first-mover advantage benefit these competitors?

Table of contents

Heart Valve Devices - Market Insights - Asia Pacific

Bhavesh Jain

Bhavesh Jain is an associate analyst on the Cardiovascular Medtech Insights team at Clarivate, specializaing in the vascular access device market. Bhavesh holds a Bachelor’s degree in Pharmaceutical Sciences from Dr. H.S Gour University and an MBA in Pharmaceutical Management from the National Institute of Pharmaceutical Education and Research, Mohali.

Contact sales Login to access report

Back to all Medtech Insights reports